Philip Huang
Chief Executive Officer bei TAIGEN BIOPHARMACEUTICALS HOLDINGS LIMITED
Profil
Kuo Long Huang is currently the Chairman, Chief Executive Officer, General Manager, and Spokesman at TaiGen Biopharmaceuticals Holdings Ltd.
He started this position in 2019.
Prior to his current role, he has a background in business administration, having obtained an MBA from the University of South Australia.
He also has an undergraduate degree from Taipei Medical University.
Aktive Positionen von Philip Huang
| Unternehmen | Position | Beginn |
|---|---|---|
| TAIGEN BIOPHARMACEUTICALS HOLDINGS LIMITED | Chief Executive Officer | 02.01.2019 |
Ausbildung von Philip Huang
| University of South Australia | Masters Business Admin |
| Taipei Medical University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| TAIGEN BIOPHARMACEUTICALS HOLDINGS LIMITED | Health Technology |
